CenterBook Partners LP Sells 252,731 Shares of Stevanato Group S.p.A. (NYSE:STVN)

CenterBook Partners LP reduced its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 70.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 106,923 shares of the company's stock after selling 252,731 shares during the period. CenterBook Partners LP's holdings in Stevanato Group were worth $2,330,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Captrust Financial Advisors raised its holdings in shares of Stevanato Group by 12.7% during the third quarter. Captrust Financial Advisors now owns 13,100 shares of the company's stock valued at $262,000 after purchasing an additional 1,480 shares during the period. Wellington Management Group LLP boosted its position in shares of Stevanato Group by 4.5% during the third quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company's stock valued at $53,872,000 after buying an additional 115,050 shares during the last quarter. AMI Asset Management Corp bought a new stake in shares of Stevanato Group in the 4th quarter worth $1,089,000. SG Americas Securities LLC increased its stake in Stevanato Group by 18.2% in the 4th quarter. SG Americas Securities LLC now owns 15,546 shares of the company's stock valued at $339,000 after buying an additional 2,389 shares during the last quarter. Finally, Jennison Associates LLC bought a new position in shares of Stevanato Group during the 4th quarter worth approximately $20,239,000.

Wall Street Analyst Weigh In

STVN has been the subject of several research analyst reports. UBS Group decreased their price target on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a research note on Friday, March 7th. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, Stevanato Group currently has a consensus rating of "Moderate Buy" and a consensus price target of €25.70 ($29.20).

Remove Ads

Stevanato Group Trading Down 0.7 %

Shares of STVN stock traded down €0.16 ($0.18) during mid-day trading on Tuesday, reaching €22.20 ($25.23). The stock had a trading volume of 74,669 shares, compared to its average volume of 352,400. The stock's 50-day moving average price is €20.51 and its two-hundred day moving average price is €20.64. The firm has a market capitalization of $6.72 billion, a PE ratio of 47.23, a price-to-earnings-growth ratio of 7.18 and a beta of 0.52. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 52-week low of €16.56 ($18.82) and a 52-week high of €29.67 ($33.72).

Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.23) EPS for the quarter, hitting the consensus estimate of €0.20 ($0.23). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €352.68 million during the quarter, compared to analyst estimates of €346.26 million. Equities analysts expect that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.